Advantages of a narrow-range, medium molecular weight hydroxyethyl starch for volume maintenance in a porcine model of fecal peritonitis

Crit Care Med. 1991 Mar;19(3):409-16. doi: 10.1097/00003246-199103000-00022.

Abstract

Objective: To compare the effectiveness of two hydroxyethyl starch solutions of different molecular weight ranges for volume maintenance in a porcine model of fecal peritonitis.

Design: Randomized prospective trial.

Setting: Laboratory investigation.

Subjects: Adolescent female pigs weighing approximately 30 kg.

Interventions: We compared diafiltered 6% pentastarch with 6% high molecular weight hetastarch for volume maintenance in a porcine model of fecal peritonitis. The number average molecular weight of pentastarch is higher than hetastarch, although the weight average molecular weight is lower, i.e., a narrow range of medium weight molecules. The infusion rate of each agent was adjusted to maintain baseline arterial Hct for less than or equal to 7 hr after instrumentation and induction of fecal peritonitis.

Main outcome measurements: The volume of fluid required to maintain arterial Hct was compared along with comparisons of hemodynamic and histologic responses associated with the two agents.

Results: Significantly less pentastarch was required to prevent hemoconcentration than hetastarch (109 +/- 22.8 vs. 150 +/- 10.3 mL/kg; p less than .05) while hemodynamics, colloid osmotic pressure, and oxygen transport responses were similar. Capillary patency was greater (21.99 +/- 3.68 vs. 10.09 +/- 1.17%; p less than .05) and mean alveolar capillary barrier thickness was less (2.36 +/- 0.13 vs. 3.06 +/- 0.17 microns; p less than .05) with pentastarch than with hetastarch, as judged by electron microscopy.

Conclusions: These data suggest that pentastarch is better retained in the circulation in capillary leak syndromes compared with hetastarch.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Female
  • Hemodynamics
  • Hydroxyethyl Starch Derivatives / therapeutic use*
  • Molecular Weight
  • Oxygen Consumption
  • Peritonitis / drug therapy*
  • Prospective Studies
  • Pulmonary Alveoli / pathology
  • Random Allocation
  • Swine

Substances

  • Hydroxyethyl Starch Derivatives